Arginine Silicate Inositol Complex Accelerates Cutaneous Wound Healing.

Area of Science:

• Biomedical Science
• Wound Healing Research
• Dermatology

Background:

• Arginine silicate inositol (ASI) complex, a blend of arginine, silicon, and inositol, demonstrates positive impacts on vascular health.
• Existing research highlights ASI's benefits for vascular systems, prompting investigation into its topical effects on tissue repair.

Purpose of the Study:

• To evaluate the efficacy of an ASI ointment in promoting wound healing in a rat model.
• To assess the biochemical and histopathological changes associated with ASI treatment on excisional wounds.

Main Methods:

• Full-thickness excisional wounds were created in rats and treated with 4% or 10% ASI ointments or placebo twice daily.
• Wound healing progress was monitored over 5, 10, and 15 days, with tissue samples collected for biochemical and histopathological analysis.
• Key biomarkers including collagen, nitric oxide synthases (iNOS, eNOS), matrix metalloproteinases (MMP-2, MMP-9), growth factors (VEGF, FGF, EGF), NF-κB, and cytokines (TNF-α, IL-1β) were quantified.

Main Results:

• ASI treatment significantly accelerated granulation tissue appearance and increased the percentage of total wound healing compared to controls (P < 0.05).
• ASI-treated wounds exhibited significantly smaller unhealed areas.
• The expression levels of iNOS, eNOS, collagen, MMP-2, MMP-9, VEGF, FGF, EGF, NF-κB, TNF-α, and IL-1β were significantly reduced in ASI-treated wounds.

Conclusions:

• Topical application of ASI ointment, particularly at a 4% concentration, demonstrates significant beneficial effects on the healing of excisional wounds in rats.
• ASI promotes wound healing by modulating key molecular pathways involved in tissue repair and inflammation.